Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

被引：0
|
作者：
C. Belliveau
M. Barkati
G. Delouya
D. Taussky
M. C. Beauchemin
C. Lambert
L. Beaulieu
D. Beliveau-Nadeau
B. Nicolas
J. F. Carrier
E. Vigneault
C. Ménard
机构：
[1] CHUM - Centre Hospitalier de l’Université de Montréal,Radiation Oncology
[2] Université Laval,Radiation Oncology, Centre universitaire de Québec
来源：
Radiation Oncology | / 17卷
关键词：
Prostate cancer; Stereotactic radiotherapy; Focal brachytherapy; Quality of life; Magnetic resonance imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
    Nicholls, Luke
    Suh, Yae-eun
    Chapman, Ewan
    Henderson, Daniel
    Jones, Caroline
    Morrison, Kirsty
    Sohaib, Aslam
    Taylor, Helen
    Tree, Alison
    van As, Nicholas
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 25 : 88 - 93
  • [22] PROSTATE SBRT BOOST RADIOTHERAPY (PBS TRIAL): A RANDOMIZED PHASE II TRIAL OF SBRT VERSUS CONVENTIONALLY-FRACTIONATED RADIOTHERAPY BOOST FOLLOWING PELVIC RADIOTHERAPY IN HIGH-RISK PROSTATE CANCER
    Mesci, Aruz
    Isfahanian, Naghmeh
    Douvi, Georgia
    Gouran-Savadkoohi, Mohammad
    Dayes, Ian
    Lukka, Himanshu
    Quan, Kimmen
    Schnarr, Kara
    Goldberg, Mira
    Hallock, Abhirami
    Chow, Tom
    Diamond, Kevin
    Jakubovic, Raphael
    Thabane, Lahane
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S64 - S64
  • [23] Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
    Ito, Kei
    Nakajima, Yujiro
    Ogawa, Hiroaki
    Furusawa, Akiko
    Murofushi, Keiko Nemoto
    Kito, Satoshi
    Kino, Nao
    Yasugi, Toshiharu
    Uno, Takashi
    Karasawa, Katsuyuki
    JAPANESE JOURNAL OF RADIOLOGY, 2024, 42 (08) : 909 - 917
  • [24] HDR brachytherapy combined to EBRT for prostate cancer: analysis of toxicities and PSA bounce of a phase II trial
    Tetreault-Laflamme, A.
    Nguyen, T. V.
    Vincent, F.
    Saad, F.
    Benoit, N.
    Fortin, B.
    Lambert, C.
    Jolicoeur, M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S566 - S566
  • [25] SBRT boost is a viable alternative to HDR brachytherapy boost for prostate cancer patients
    Grabec, D.
    Majdic, A.
    Carman, J.
    Kragelj, B.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1239 - S1240
  • [26] A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)
    Isfahanian, Naghmeh
    Lukka, Himanshu
    Dayes, Ian
    Quan, Kimmen
    Schnarr, Kara Lynne
    Douvi, Georgia
    Goldberg, Mira
    Wright, Jim
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : E410 - E415
  • [27] PSA Kinetics: HDR prostate brachytherapy boost in combination with external beam radiotherapy
    Rodda, S.
    Sun, F.
    Henry, A.
    Franks, K.
    Bottomley, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S625 - S625
  • [28] Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer
    Groen, Veerle H.
    Haustermans, Karin
    Pos, Floris J.
    Draulans, Cedric
    Isebaert, Sofie
    Monninkhof, Evelyn M.
    Smeenk, Robert J.
    Kunze-Busch, Martina
    de Boer, Johannes C. J.
    van Zijp, Jochem van der Voort
    Kerkmeijer, Linda G. W.
    van der Heide, Uulke A.
    EUROPEAN UROLOGY, 2022, 82 (03) : 252 - 257
  • [29] HDR brachytherapy vs stereotactic boost in treatment of prostate cance: comparison of safety profile
    Novikov, S.
    Gotovchikova, M.
    Ilin, N.
    Novikov, R.
    Merezhko, Y.
    Melnik, J.
    Kanaev, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1085 - S1085
  • [30] Multiparametric imaging guided HDR interventional radiotherapy (brachytherapy) boost in localized prostate cancer: a multidisciplinary experience
    Tagliaferri, L.
    Alemanno, G.
    Fionda, B.
    Alitto, A. R.
    Frascino, V.
    Cellini, F.
    Lancellotta, V.
    Placidi, E.
    Morganti, A. G.
    Kovacs, G.
    Giordano, A.
    Manfredi, R.
    Valentini, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (09) : 4175 - 4184
12345